Daiki Hashimoto won his fifth straight artistic gymnastics national championships on Sunday after coming out on top in a battle between the last two Olympic men's individual all-around gold medalists.

Daiki Hashimoto poses for a photo after winning his fifth straight artistic gymnastics national championships at Takasaki Arena in Gunma Prefecture on April 20, 2025. (Kyodo) TAKASAKI, Japan ...

RIZIN will hold two cards in May with the start of the heavyweight grand prix and championships being defended. On May 4, ...

The ADC secured approval in over 75 nations for the treatment of HER2-positive breast cancer. Credit: Maria Sbytova / Shutterstock. Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) ...

SUTNY Sumitomo Mitsui Trust Group, Inc.

AstraZeneca and Daiichi Sankyo are aiming to establish their star antibody-drug conjugate (ADC) Enhertu as a first-line treatment in HER2-positive breast cancer after recording “highly ...

Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive ...

Daiichi Sankyo and AstraZeneca's Enhertu (trastuzumab deruxtecan) with pertuzumab has shown progression-free survival (PFS) improvement in the Phase III DESTINY-Breast09 trial, when used as a ...

A cancer drug from partners AstraZeneca and Daiichi Sankyo currently approved as a second-line or later treatment for metastatic breast cancer has interim clinical data showing it helped patients ...